Onset of epidermolysis bullosa acquisita under therapy with ustekinumab for the treatment of Crohn disease

Clin Exp Dermatol. 2023 Mar 1;48(3):245-246. doi: 10.1093/ced/llac077.

Authors

Thilo Gambichler¹, E Schmidt², Christina H Scheel¹, Maria Chatzipantazi¹

Affiliations

¹ Skin Cancer Center, Department of Dermatology, Ruhr-University Bochum, Bochum, Germany; and.
² Department of Dermatology and Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.

PMID: 36763773
DOI: 10.1093/ced/llac077

No abstract available

Publication types

Letter

MeSH terms

Crohn Disease*
Epidermolysis Bullosa Acquisita*
Epidermolysis Bullosa*
Humans
Ustekinumab

Substances

Ustekinumab